Phase II prospective study of radiosurgery for multiple CNS metastatic disease.

被引：0
|
作者：
Kubicek, Greg J.
LaCouture, Tamara A.
Turtz, Alan
Patel, Ashish Bharat
Hughes, Lesley
Bexon, Anne
Xue, Jinyu
Choi, Micheal
Saraiya, Piya V.
Lerman, Nati
Asbell, Sucha O.
Goldman, Howard Warren
机构：
[1] UPMC, Pittsburgh, PA USA
[2] Cooper Univ Hosp, Camden, NJ USA
[3] Univ Med & Dent New Jersey, Cooper Hosp, Camden, NJ 08103 USA
[4] Cooper, MD Anderson Canc Ctr, Camden, NJ USA
[5] St Joseph Medcl Ctr, Reading, PA USA
[6] Cooper, Camden, NJ USA
[7] Cooper Canc Inst, Camden, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20555
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prospective Multicenter Phase II Study of Biweekly TAS-102 and Bevacizumab for Metastatic Colorectal Cancer
    Ishizaki, Tetsuo
    Mazaki, Junichi
    Enomoto, Masanobu
    Shigoka, Masatoshi
    Kasahara, Kenta
    Matsudo, Takaaki
    Kawakita, Hideaki
    Nagakawa, Yuichi
    Katsumata, Kenji
    Tsuchida, Akihiko
    ANTICANCER RESEARCH, 2021, 41 (04) : 2157 - 2163
  • [42] Chemoimmunohormonal therapy with carmustine, dacarbazine, cisplatin, tamoxifen, and interferon for metastatic melanoma - A prospective phase II study
    Stein, ME
    Bernstein, Z
    Tsalic, M
    Drumea, K
    Steiner, M
    Sklar, Z
    Haim, N
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (05): : 460 - 463
  • [43] Correlation of circulating tumor DNA and recurrence in patients with metastatic colorectal cancer with no evidence of disease: An open-label, prospective, phase II study
    Li, Yaqi
    Hu, Xiang
    Sun, Xiaoran
    Wang, Guoqiang
    Liu, Fangqi
    Zhao, Kunli
    Li, Chengcheng
    Li, Wenhua
    Pan, Qi
    Wang, Jing
    Li, Bing
    Cai, Shangli
    Peng, Junjie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] Report of a phase II study of sphingosomal vincristine (SV) in patients with relapsed or refractory Hodgkin's disease.
    Fayad, L
    Romaguera, J
    Hart, S
    Younes, A
    Pro, B
    Hagemeister, F
    Mclaughlin, P
    Dang, N
    Pretti, A
    Sarris, A
    Gil, F
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 591S - 591S
  • [45] Disrupting TNF signaling in pancreatic cancer: A phase I/II clinical study in patients with advanced disease.
    Kosuri, KV
    Bekaii-Saab, T
    Bender, J
    Criswell, T
    Kane, Y
    Chidiac, T
    Young, D
    Guttridge, D
    Caligiuri, M
    Villalona-Calero, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 333S - 333S
  • [46] A Phase II Prospective Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases
    Beal, K.
    Chan, K.
    Chan, T.
    Yamada, Y.
    Narayana, A.
    Lymberis, S.
    Gutin, P.
    Tabar, V.
    Brennan, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S126 - S127
  • [47] Epicure: efficacy of nintedanib as a treatment for epistaxis in HHT disease. A national, randomized, multicenter phase II study
    Hermann, R.
    Fargeton, A.
    Decullier, E.
    Chinet, T.
    Corre, R.
    Gilbert-Dussardier, B.
    Grobost, V
    Hatron, P.
    Lavigne, C.
    Leguy-Seguin, V
    Parrot, A.
    Riviere, S.
    Seguier, J.
    Beaudoin, M.
    Roux, A.
    Bel, F.
    Gervaise, C.
    Faure, F.
    Dupuis-Girod, S.
    ANGIOGENESIS, 2019, 22 (04) : 629 - 630
  • [48] A phase II multicenter study of the proteasome inhibitor bortezomib (VELCADE™, formerly PS-341) in multiple myeloma patients (pts) with relapsed/refractory disease.
    Richardson, P
    Barlogie, B
    Berenson, J
    Traynor, A
    Singhal, S
    Jagannath, S
    Irwin, D
    Rajkumar, V
    Srkalovic, G
    Alsina, M
    Alexanian, R
    Siegel, D
    Orlowski, RZ
    Kuter, D
    Limentani, SA
    Lee, S
    Esseltine, DL
    Kauffman, M
    Adams, J
    Schenkein, DP
    Anderson, KC
    BLOOD, 2002, 100 (11) : 104A - 104A
  • [49] Phase II prospective study of sequential myeloablative chemotherapy with stem cell rescue for the treatment of selected high-risk cns tumors and recurrent CNS tumors
    Rosenfeld, Amy
    Rademaker, Alfred
    Schaefer, Colleen
    Fouts, Molly
    Duerst, Reggie
    Jacobsohn, David
    Kletzel, Morris
    Stewart, Goldman
    NEURO-ONCOLOGY, 2008, 10 (03) : 422 - 423
  • [50] Gamma knife stereotactic radiosurgery as an effective tool in primary CNS lymphoma: Evaluation of stereotactic radiosurgery and methotrexate treatment in a prospective and observational clinical research study
    Alvarez-Pinzon, Andres M.
    Wolf, Aizik
    Valerio, Jose E.
    Borro, Matteo
    Herrera, Daniela
    Alonso, Jose Ramon
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2021, 201
12345